COLL

Collegium Pharmaceutical, Inc.

36.26 USD
-0.09 (-0.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Collegium Pharmaceutical, Inc. stock is up 8.27% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 8 February’s closed higher than January. 100% of analysts rate it a buy.

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. develops and commercializes medicines for pain management. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone.